Early research (Phase 1)Study completedNCT01656265What this trial is testingStudy of ARQ 197 in Hepatocellular Carcinoma (HCC)Who this might be right forAdvanced Hepatocellular Carcinoma Kyowa Kirin Co., Ltd. 24
Not applicableLooking for participantsNCT06887348What this trial is testingAssess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3Who this might be right forMelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more Replimune Inc. 50
Early research (Phase 1)Looking for participantsNCT06307925What this trial is testingA Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor HC Biopharma Inc. 122
Early research (Phase 1)Looking for participantsNCT06326502What this trial is testingA Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaAdvanced Hepatocellular CarcinomaLiver Cancer Etnova Therapeutics Corp. 50
Testing effectiveness (Phase 2)Looking for participantsNCT07227012What this trial is testingLearn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.Who this might be right forCarcinoma, HepatocellularHepatocellular CancerHepatocellular Carcinoma+4 more Pfizer 138
Testing effectiveness (Phase 2)Study completedNCT00987935What this trial is testingA Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma PatientsWho this might be right forCarcinoma, Hepatocellular Boehringer Ingelheim 134
Testing effectiveness (Phase 2)UnknownNCT05603039What this trial is testingA Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular CarcinomaWho this might be right forAdvanced Liver Cancer Qilu Pharmaceutical Co., Ltd. 80
Not applicableLooking for participantsNCT06061276What this trial is testingBTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCCWho this might be right forLiver DiseasesHepatocellular CarcinomaImmunotherapy+2 more Sun Yat-sen University 40
Testing effectiveness (Phase 2)UnknownNCT05622136What this trial is testingDose-escalation of Regorafenib in Advanced Hepatocellular CarcinomaWho this might be right forLiver CancerHepatocellular Carcinoma Instituto do Cancer do Estado de São Paulo 28
Testing effectiveness (Phase 2)UnknownNCT05171309What this trial is testingCamrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCCWho this might be right forHepatocellular Carcinoma Nanfang Hospital, Southern Medical University 35
Testing effectiveness (Phase 2)Ended earlyNCT03970616What this trial is testingTivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma AVEO Pharmaceuticals, Inc. 27
Early research (Phase 1)Not Yet RecruitingNCT06822985What this trial is testingQL1706 As Second-line Treatment in Patients with Advanced Hepatocellular CarcinomaWho this might be right forHCC - Hepatocellular Carcinoma Wan-Guang Zhang 21
Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Early research (Phase 1)Active Not RecruitingNCT02817633What this trial is testingTSR-022 in Participants With Advanced Solid Tumors (AMBER)Who this might be right forNeoplasms Tesaro, Inc. 463
Early research (Phase 1)Looking for participantsNCT06873659What this trial is testingSON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorGastric CancerLiver Cancer Qurgen Inc. 96
Testing effectiveness (Phase 2)Ended earlyNCT00862082What this trial is testingRandomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)Who this might be right forHepatocellular Carcinoma Proacta, Incorporated 14
Early research (Phase 1)Study completedNCT01337050What this trial is testingAsian Phase I Study Of PF-03446962Who this might be right forNeoplasms Pfizer 36
Testing effectiveness (Phase 2)Study completedNCT04798781What this trial is testingSafety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular CarcinomaWho this might be right forGastric CancerHepatocellular Carcinoma Andrew Hendifar, MD 16
Testing effectiveness (Phase 2)UnknownNCT04014101What this trial is testingSHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Shanghai Zhongshan Hospital 40
Testing effectiveness (Phase 2)Study completedNCT04444167What this trial is testingAnti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Akeso 59